fbpx
close read more
News

Olivier Laureau confirmed as Second Vice President of EFPIA

16/06/2021

Olivier Laureau confirmed as Second Vice President of EFPIA

On June 16th 2021, Olivier Laureau, President of Servier, was confirmed as Second Vice President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) during its General Assembly.

EFPIA logo

As Second Vice President, Olivier Laureau will continue to defend the pharmaceutical sector, bringing in Servier’s values as well as defending the interests of the EFPIA European Mid-Size Pharmaceutical Companies.

He will be working together with the President (Hubertus Von Baumbach from Boehringer Ingelheim) and the first Vice-President (Lars Fruergaard Jørgensen from Novo Nordisk) leading the work of the federation for a two-year mandate.

“Recent events have demonstrated the key role medical innovation plays in keeping our society safe and healthy” said Olivier Laureau.  “Our ambition is for Europe to be a world leader in life science. Realising that goal means EFPIA and its membership working with the EU and Member States to build a world-class regulatory system, a strong and predictable IP framework and a next generation life sciences eco-system that delivers for patients across Europe and around the world.”

Servier is a member of EFPIA since 1997.

 

Read EFPIA’s press release

Last news

News
23/06/2022
Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
News
15/06/2022
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
News
01/06/2022
Patient associations’ perception of pharmaceutical companies: Servier is making progress!